Farhad Khimani

2.6k total citations
67 papers, 741 citations indexed

About

Farhad Khimani is a scholar working on Oncology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Farhad Khimani has authored 67 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 24 papers in Hematology and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Farhad Khimani's work include CAR-T cell therapy research (23 papers), Hematopoietic Stem Cell Transplantation (18 papers) and Acute Lymphoblastic Leukemia research (13 papers). Farhad Khimani is often cited by papers focused on CAR-T cell therapy research (23 papers), Hematopoietic Stem Cell Transplantation (18 papers) and Acute Lymphoblastic Leukemia research (13 papers). Farhad Khimani collaborates with scholars based in United States, Pakistan and Denmark. Farhad Khimani's co-authors include Frederick L. Locke, Bijal Shah, Julio C. Chávez, Aleksandr Lazaryan, Marco L. Davila, Michael D. Jain, Hien Liu, Taiga Nishihori, Christina A. Bachmeier and Gabriel Krivenko and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Farhad Khimani

59 papers receiving 718 citations

Peers

Countries citing papers authored by Farhad Khimani

Since Specialization

Citations

This map shows the geographic impact of Farhad Khimani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Khimani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Khimani more than expected).

Fields of papers citing papers by Farhad Khimani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhad Khimani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Khimani. The network helps show where Farhad Khimani may publish in the future.

Co-authorship network of co-authors of Farhad Khimani

This figure shows the co-authorship network connecting the top 25 collaborators of Farhad Khimani. A scholar is included among the top collaborators of Farhad Khimani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhad Khimani. Farhad Khimani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide 2025 ·Blood Advances ·Dipenkumar Modi, Yosra Aljawai, Todd E. DeFor, Caitrin Bupp, Monzr M. Al Malki, Javier Bolaños‐Meade, Mahasweta Gooptu, Antonio Jiménez, Hongtao Liu, (unknown), Marco Mielcarek, Brian C. Shaffer, Bronwen E. Shaw, Stephen R. Spellman, Heather E. Stefanski, Jeffery J. Auletta, Steven M. Devine, Farhad Khimani, Ramzi Abboud	1
2	Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors 2024 ·Journal of Clinical Oncology ·Brian C. Shaffer, Mahasweta Gooptu, Todd E. DeFor, Martin Maiers, Javier Bolaños‐Meade, Ramzi Abboud, Adrienne Briggs, Farhad Khimani, Dipenkumar Modi, Richard Newcomb, Elizabeth J. Shpall, Caitrin Bupp, Stephen R. Spellman, Heather E. Stefanski, Bronwen E. Shaw, Jeffery J. Auletta, Steven M. Devine, Antonio Jiménez, Monzr M. Al Malki	20
3	New Approaches for the Treatment of AML beyond the 7+3 Regimen: Current Concepts and New Approaches 2024 ·Cancers ·(unknown), (unknown), Farhad Khimani	12
4	Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant 2024 ·Clinical Lymphoma Myeloma & Leukemia ·Filip Ionescu, (unknown), (unknown), David A. Sallman, Kendra Sweet, Rami S. Komrokji, Onyee Chan, Andrew Kuykendall, Eric Padron, Rawan Faramand, Nelli Bejanyan, Farhad Khimani, Hany Elmariah, Joseph Pidala, Asmita Mishra, Lia Perez, Taiga Nishihori, Jeffrey E. Lancet	2
5	Feasibility and Toxicity of Full-Body Volumetric Modulated Arc Therapy Technique for High-Dose Total Body Irradiation 2023 ·Technology in Cancer Research & Treatment ·(unknown), Casey Liveringhouse, Nicholas Figura, Joseph Weygand, (unknown), (unknown), (unknown), Michael L. Nieder, Rawan Faramand, Farhad Khimani, Sungjune Kim, Timothy J. Robinson, Peter A.S. Johnstone, José Peñagarícano, Kujtim Latifi	4
6	JAK2/mTOR Inhibition Fails to Prevent Acute Gvhd Despite Reduced Th1/Th17 Cells: Final Phase II Trial Results 2023 ·Blood ·Joseph Pidala, Shernan G. Holtan, Kelly Walton, Jongphil Kim, Hany Elmariah, Asmita Mishra, Nelli Bejanyan, Taiga Nishihori, Farhad Khimani, Lia Perez, Rawan Faramand, Marco L. Davila, Claudio Anasetti, Daniel J. Weisdorf, Bruce R. Blazar, Jeffrey S. Miller, Veronika Bachanová, (unknown), Brian C. Betts	1
7	Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-versus-Host Disease 2023 ·Transplantation and Cellular Therapy ·Rebecca Gonzalez, (unknown), (unknown), Joseph Pidala, Aleksandr Lazaryan, Lia Perez, Farhad Khimani, Rawan Faramand	5
8	CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease 2023 ·Clinical Lymphoma Myeloma & Leukemia ·Uroosa Ibrahim, (unknown), Julio C. Chávez, Farhad Khimani, Michael D. Jain, Frederick L. Locke, Keren Osman, Aleksandr Lazaryan	1
9	Impact of conditioning regimen intensity on the outcomes of peripheral T‐cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T‐cell lymphoma patients undergoing allogeneic transplant 2022 ·British Journal of Haematology ·Malvi Savani, Kwang Woo Ahn, Yue Chen, Sairah Ahmed, Amanda F. Cashen, Mazyar Shadman, Dipenkumar Modi, Farhad Khimani, Corey Cutler, Jasmine Zain, Jonathan E. Brammer, Andrew R. Rezvani, Timothy S. Fenske, Craig S. Sauter, Mohamed A. Kharfan‐Dabaja, Alex F. Herrera, Mehdi Hamadani	12
10	Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results 2021 ·Clinical Cancer Research ·Joseph Pidala, Kelly Walton, Hany Elmariah, Jongphil Kim, Asmita Mishra, Nelli Bejanyan, Taiga Nishihori, Farhad Khimani, Lia Perez, Rawan Faramand, Marco L. Davila, Michael L. Nieder, Elizabeth M. Sagatys, Shernan G. Holtan, Nicholas J. Lawrence, Harshani R. Lawrence, Bruce R. Blazar, Claudio Anasetti, Saı̈d M. Sebti, Brian C. Betts	15
11	Abstract 9828: Active Surveillance of Cardiotoxicity with Cardiac Biomarkers During Chimeric Antigen Receptor T-Cell Therapy 2021 ·Circulation ·Dae Hyun Lee, Sanjay Chandrasekhar, Michael D. Jain, Julio C. Chávez, Bijal Shah, Aleksandr Lazaryan, Farhad Khimani, Taiga Nishihori, Christina A. Bachmeier, Michael G. Fradley, Daniel Jeong, Frederick L. Locke, Guilherme José Pimentel Lopes de Oliveira, Mohammed Alomar	2
12	A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention 2021 ·Blood Advances ·Lia Perez, Hugo F. Fernández, Mohamed A. Kharfan‐Dabaja, Farhad Khimani, Brian C. Betts, Asmita Mishra, Ernesto Ayala, Frederick L. Locke, (unknown), Michael L. Nieder, Joseph Pidala, (unknown), John J. Powers, Eva Sahakian, Ram Thapa, Xuefeng Wang, Claudio Anasetti	9
13	Ruxolitinib resistance or intolerance in steroid‐refractory acute graft‐versus‐host disease — a real‐world outcomes analysis 2021 ·British Journal of Haematology ·Sameem Abedin, (unknown), Mark A. Schroeder, Rizwan Romee, (unknown), Muhamad Alhaj Moustafa, Mohamed A. Kharfan‐Dabaja, Jeanne Palmer, William J. Hogan, Mehrdad Hefazi, (unknown), Shernan G. Holtan, Zachariah DeFilipp, Reena Jayani, Bhagirathbhai Dholaria, Joseph Pidala, Farhad Khimani, Michael R. Grunwald, (unknown), Mehdi Hamadani	10
14	Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission 2021 ·Blood ·Mazyar Shadman, Marcelo C. Pasquini, Kwang Woo Ahn, Yue Chen, Cameron J. Turtle, Peiman Hematti, Jonathon B. Cohen, Farhad Khimani, Siddhartha Ganguly, Reid W. Merryman, Jean A. Yared, Frederick L. Locke, Nausheen Ahmed, Pashna N. Munshi, Amer Beitinjaneh, Patrick M. Reagan, Alex F. Herrera, Craig S. Sauter, Mohamed A. Kharfan‐Dabaja, Mehdi Hamadani	62
15	Factors Affecting Lymphocyte Collection Efficiency and Manufactured Product Specification during Leukapheresis for Diffuse Large B Cell Lymphoma Patients Treated with Commercial Tisagenlecleucel 2020 ·Blood ·Ariel Perez Perez, Christina A. Bachmeier, (unknown), (unknown), Aleksandr Lazaryan, Julio C. Chávez, Claudio Anasetti, Bijal Shah, Farhad Khimani, Taiga Nishihori, Marco L. Davila, Frederick L. Locke, Michael D. Jain, Hien Liu	3
16	High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma 2020 ·Blood Advances ·Erin Dean, Rahul Mhaskar, Hong Lü, (unknown), Gabriel Krivenko, Aleksandr Lazaryan, Christina A. Bachmeier, Julio C. Chávez, Taiga Nishihori, Marco L. Davila, Farhad Khimani, Hien Liu, Javier Pinilla‐Ibarz, Bijal Shah, Michael D. Jain, Yoganand Balagurunathan, Frederick L. Locke	146
17	Patterns of Failure Following Chimeric Antigen Receptor T-cell (CAR-T) Therapy 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Nicholas Figura, Michael D. Jain, Austin J. Sim, Julio C. Chávez, Bijal Shah, Farhad Khimani, Aleksandr Lazaryan, (unknown), (unknown), (unknown), Timothy J. Robinson	1
18	Allogeneic Hematopoietic Cell Transplantation for Richter Syndrome: A Single-Center Experience 2017 ·Clinical Lymphoma Myeloma & Leukemia ·Mohamed A. Kharfan‐Dabaja, Ambuj Kumar, (unknown), Farhad Khimani, Mohammad Hussaini, Ernesto Ayala, Taiga Nishihori, Bijal Shah, Frederick L. Locke, Javier Pinilla‐Ibarz, Julio C. Chávez	16
19	Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention 2017 ·Bone Marrow Transplantation ·Farhad Khimani, (unknown), (unknown), Erin Dean, (unknown), Brian C. Betts, Taiga Nishihori, Frederick L. Locke, Asmita Mishra, Lia Perez, Ernesto Ayala, M A Kharfan-Dabaja, Michael L. Nieder, Hugo F. Fernández, Claudio Anasetti, Joseph Pidala	8
20	Reasons for migration among medical students from Karachi 2007 ·Medical Education ·Nadir Ali Syed, Farhad Khimani, Marie Andrades, (unknown), (unknown)	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact